The DOI matches its Crossref record; 259 of the 259 references it cites were found in a registry or an index.
A precision medicine approach to pharmacological adjuncts to extinction: a call to broaden research
Open accessAbstract
There is a pressing need to improve treatments for anxiety. Although exposure-based therapy is currently the gold-standard treatment, many people either do not respond to this therapy or experience a relapse of symptoms after treatment has ceased. In recent years, there have been many novel pharmacological agents identified in preclinical research that have potential as adjuncts for exposure therapy, yet very few of these are regularly integrated into clinical practice. Unfortunately, the robust effects observed in the laboratory animal often do not translate to a clinical population. In this review, we discuss how age, sex, genetics, stress, medications, diet, alcohol, and the microbiome can vary across a clinical population and yet are rarely considered in drug development. While not an exhaustive list, we have focused on these factors because they have been shown to influence an individual's vulnerability to anxiety and alter the neurotransmitter systems often targeted by pharmacological adjuncts to therapy. We argue that for potential adjuncts to be successfully translated from the lab to the clinic empirical research must be broadened to consider how individual difference factors will influence drug efficacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the benefit of DCS-augmented EBT seems to be reduced in patients receiving antidepressants (King et al., 2018;Otto et al., 2016).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as King et al., 2018
Citations
Cites
Items 201–259 of 259
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900201 · Cited by 76
d-Cycloserine Augmentation of Cognitive Behavioral Therapy for Anxiety Disorders: an Update
Hofmann, S. G., Otto, M. W., Pollack, M. H., & Smits, J. A. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0532-2 · Cited by 76
Augmentation of exposure therapy with post-session administration of D-cycloserine
Tart, C. D., Handelsman, P. R., DeBoer, L. B., Rosenfield, D., Pollack, M. H., Hofmann, S. G., Powers, M. B., Otto, M. W., & Smits, J. A. J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.09.024 · Cited by 75
Hohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., Uhr, M., Holsboer, F., & Ising, M. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu087 · Cited by 74
The patient with comorbid depression and anxiety: the unmet need.
Bakish, D. (1999) · PubMed · Cited by 73
Scheeringa, M. S., & Weems, C. F. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0106 · Cited by 72
Wilker, S., Pfeiffer, A., Kolassa, S., Elbert, T. R., Lingenfelder, B., Ovuga, E. B. L., Papassotiropoulos, A., de Quervain, D. J. ‐., & Kolassa, I. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.49 · Cited by 71
Influence of ethanol withdrawal on fear memory: Effect of d-cycloserine
Bertotto, M. E., Bustos, S. G., Molina, V. A., & Martijena, I. D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.013 · Cited by 70
Gimeno, C. P., Dorado, M. L., Roncero, C., Szerman, N., Vega, P., Balanzá‐Martínez, V., & Alvarez, E. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00173 · Cited by 63
Post-extinction fluoxetine treatment prevents stress-induced reemergence of extinguished fear
Deschaux, O., Zheng, X., Lavigne, J., Nachon, O., Cleren, C., Moreau, J.-L., & Garcia, R. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2806-x · Cited by 62
Baker, K., & Reichelt, A. C. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.10.002 · Cited by 61
Self-citationColle, R., Deflesselle, É., Martin, S., David, D. J. P., Hardy, P., ŢĂRANU, A. M., Falissard, B., Verstuyft, C., & Corruble, E. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.56 · Cited by 60
d-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
Hofmann, S. G., Wu, J. Q., & Boettcher, H. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-11 · Cited by 59
Pharmacological enhancement of fear reduction: preclinical models
Graham, B. M., Langton, J. M., & Richardson, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01175.x · Cited by 57
Self-citationLattal, K. M. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.6.1280 · Cited by 57
Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear
Deschaux, O., Spennato, G., Moreau, J., & Garcia, R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2134-y · Cited by 57
Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats
Zbukvic, I. C., Park, C. H. J., Ganella, D. E., Lawrence, A. J., & Kim, J. H. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00032 · Cited by 57
Carbohydrate-enriched diet predispose to anxiety and depression-like behavior after stress in mice
Santos, C. J., Ferreira, A. V. M., de Oliveira, A. L. F., Oliveira, M. C., Gomes, J. S., & de Aguiar, D. C. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1213529 · Cited by 56
The genetics of selective serotonin reuptake inhibitors
Kroeze, Y., Zhou, H., & Homberg, J. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.015 · Cited by 55
Colle, R., Gressier, F., Verstuyft, C., Deflesselle, E., Lépine, J.-P., Ferreri, F., Hardy, P., Guilloux, J.-P., Petit, A.-C., Fève, B., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.013 · Cited by 55
Cowan, C. S. M., Callaghan, B. L., & Richardson, R. (2013) · Behavioral Neuroscience · doi:10.1037/a0034118 · Cited by 55
Self-citationCallaghan, B. L., Cowan, C. S. M., & Richardson, R. (2016) · Psychological Science · doi:10.1177/0956797616653103 · Cited by 55
Self-citationMinelli, A., Maffioletti, E., Cloninger, C. R., Magri, C., Sartori, R., Bortolomasi, M., Congiu, C., Bignotti, S., Segala, M., Giacopuzzi, M., et al. (2013) · Depression and Anxiety · doi:10.1002/da.22158 · Cited by 54
Roberts, R. E., & Duong, H. T. (2013) · Psychological Medicine · doi:10.1017/s0033291712002991 · Cited by 54
Graham, B. M., Li, S. H., Black, M., & Öst, L. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.019 · Cited by 54
Bruce, L. C., Heimberg, R. G., Goldin, P. R., & Gross, J. J. (2013) · Depression and Anxiety · doi:10.1002/da.22112 · Cited by 51
VAL66MET BDNF GENOTYPES IN MELANCHOLIC DEPRESSION: EFFECTS ON BRAIN STRUCTURE AND TREATMENT OUTCOME
Cardoner, N., Soria, V., Gratacòs, M., Hernández‐Ribas, R., Pujol, J., López‐Solà, M., Deus, J., Urretavizcaya, M., Estivill, X., Menchón, J. M., et al. (2012) · Depression and Anxiety · doi:10.1002/da.22025 · Cited by 50
Graham, B. M., Callaghan, B. L., & Richardson, R. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.012 · Cited by 49
Self-citationNave, A. M., Tolin, D., & Stevens, M. (2012) · Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07564 · Cited by 48
Haaker, J., Lonsdorf, T. B., & Kalisch, R. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.016 · Cited by 47
Do Anxiety Disorders Play a Role in Adolescent Obesity?
ROBERTS, R. E., & Duong, H. T. (2016) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9786-8 · Cited by 47
Yan, T., Wang, L., Kuang, W., Xu, J., Li, S., Chen, J., & Yang, Y. (2014) · Asia-Pacific Psychiatry · doi:10.1111/appy.12148 · Cited by 46
Effect of age on pharmacokinetics and pharmacodynamics in man.
Klotz, U. E. (1998) · PubMed · Cited by 46
Carr, C. J. (1982) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.000315 · Cited by 43
Effects of D-Cycloserine on Extinction: Consequences of Prior Exposure to Imipramine
Werner-Seidler, A., & Richardson, R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.010 · Cited by 43
Self-citationRada, P. V., Avena, N. M., Barson, J. R., Hoebel, B. G., & LEIBOWITZ, S. F. (2012) · Brain Sciences · doi:10.3390/brainsci2020242 · Cited by 42
Park, C. H. J., Ganella, D. E., & Kim, J. H. (2017) · Learning & Memory · doi:10.1101/lm.045831.117 · Cited by 37
The use of magnetic resonance spectroscopy for assessing the effect of diet on cognition
Scavuzzo, C. J., Moulton, C. J., & Larsen, R. J. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1218191 · Cited by 35
Callaghan, B. L., & Richardson, R. (2014) · Behavioral Neuroscience · doi:10.1037/bne0000009 · Cited by 33
Self-citationTocchetto, A. G., Salum, G. A., Blaya, C., Teche, S. P., Isolan, L., Bortoluzzi, A., Silva, R. R. E., Becker, J. A., Bianchin, M. M., Rohde, L. A., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.044 · Cited by 32
Kim, S. J., Cho, S., Jang, H. M., Shin, J., Park, P.-W., Lee, Y. J., Cho, I. H., Choi, J.-E., & Lee, H. (2009) · Neuropsychobiology · doi:10.1159/000258639 · Cited by 31
Oxytocin and the emergence of individual differences in the social regulation of stress
Chen, F. S., Heinrichs, M., & Johnson, S. C. (2017) · Social and Personality Psychology Compass · doi:10.1111/spc3.12332 · Cited by 31
Popova, D., Ágústsdóttir, A., Lindholm, J., Mazulis, U., Akamine, Y., Castrén, E., & Karpova, N. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.04.002 · Cited by 26
Baker, K., & Richardson, R. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.10.014 · Cited by 22
Self-citationMin, J., Lee, H., Lee, S., Park, Y.-M., Kang, S., & Chae, J. (2012) · Neuropsychobiology · doi:10.1159/000342384 · Cited by 21
A sensory-enhanced context allows renewal of an extinguished fear response in the infant rat
Revillo, D., Molina, J. C., Paglini, M. G., & Arias, C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.027 · Cited by 20
NEUROPHARMACOLOGY IN THE ELDERLY
Kompoliti, K., & Goetz, C. G. (1998) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70083-9 · Cited by 19
Extinction learning is slower, weaker and less context specific after alcohol
Bisby, J., King, J., Sulpizio, V., Dégeilh, F., Curran, H., & Burgess, N. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.07.014 · Cited by 17
Burke, M. V., & Small, D. M. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.02.036 · Cited by 17
The mesolimbic system and eating addiction: what sugar does and does not do
de Jong, J. W., Vanderschuren, L. J. M. J., & Adan, R. A. H. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.03.004 · Cited by 17
Hassan, A. N. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17ac11999 · Cited by 16
Pharmacogenomics in Practice: A Case Report of Personalized Inpatient Psychiatric Care
Madan, A., Walker, C. R., Weinstein, B. L., & Fowler, J. C. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.9 · Cited by 14
Hippocampal encoding of interoceptive context during fear conditioning
Yoo, S.-W., Bae, M. H., Tovar‐y‐Romo, L. B., & Haughey, N. J. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.254 · Cited by 13
Increasing Childhood Trauma in Canada: Findings From the National Population Health Survey, 1994/95
Thompson, A. H., & Cui, X. (2000) · Canadian Journal of Public Health · doi:10.1007/bf03404271 · Cited by 12
Sugimoto, A., Suzuki, Y., Endo, T., Matsumoto, K., Sugiyama, T., & Someya, T. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0119 · Cited by 10
Reinstatement of an extinguished fear conditioned response in infant ratsPreprint
Revillo, D., Trebucq, G., Paglini, M. G., & Arias, C. (2015) · Learning & Memory · doi:10.1101/lm.038919.115 · Cited by 10
Schrödinger’s Cat and d -Cycloserine to Augment Exposure Therapy—Both Are Alive and Dead
Hofmann, S. G. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1132 · Cited by 8
Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam
Beekman (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1099-1166(1998100)13:10 · Cited by 2
Research works printed but not linked: 1
- Hammad T (2004) Review and evaluation of clinical data: relationship between psychotropic drugs and pediatric suicidality. US Food and Drug Administration, Rockville
Cited by
Sorted by citations
Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107402 · Cited by 236
Mayo, L. M., Asratian, A., Lindé, J., Morena, M., Haataja, R., Hammar, V., Augier, G., Hill, M. N., & Heilig, M. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.034 · Cited by 216
Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear
Bisby, M. A., Richardson, R., & Baker, K. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109834 · Cited by 15
Self-citationEditorial: the psychopharmacology of extinction—from theory to therapy
Milton, A. L., & Holmes, A. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5152-9 · Cited by 14
Harmon‐Jones, S. K., Cowan, C. S. M., Shnier, N. L., & Richardson, R. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103763 · Cited by 9
Self-citation
Metadata
- Authors
- King, G., Baker, K. D., Bisby, M. A., Chan, D., Cowan, C. S. M., Stylianakis, A. A., Zimmermann, K. S., & Richardson, R.
- Affiliations
- UNSW Sydney (AU)
- University College Cork (IE)
- Corresponding author
- King, Gabrielle
- ORCID
- Venue
- Psychopharmacology
- Published
- 2018-08-16
- Volume
- 236
- Issue
- 1
- Pages
- 143-161
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2886849746
- Cited by
- 6
- References
- 258
- Citations by year
- 2022: 1 · 2020: 1 · 2019: 4
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- precision medicine, extinction, anxiety disorders, exposure therapy, individual differences, sex differences, age effects, genetic factors, stress, diet, alcohol, gut microbiota, translational research, drug development, neurotransmitter systems
- MeSH terms
- Drug Development, Animals, Anxiety, Brain, Extinction, Psychological, Humans, Anti-Anxiety Agents, Neurotransmitter Agents, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review